Claim(permalink)
The development of REGN-COV2, the experimental “anti-viral antibody cocktail” given to U.S. President Donald Trump to treat COVID-19, involved the use of human fetal tissues and embryonic stem cells.
Factors
veracity
Political Leaning
Sentiment
Date published
2020-10-12
Entities
MarsCell surface receptorMiracle DrugEmbryonic stem cellEli Lilly and CompanyEmergency Use AuthorizationViral loadPretty Little LiarsCabinet of the United StatesCocktailBiotechnologyStem cellWalter Reed National Military Medical CenterAlexandriaRespiratory diseaseUterusAdenoviridaeMutationSnopesDavid BowieKidneyGenetic engineeringMedicationStanford UniversityAntibodyFetusImmune systemFood and Drug AdministrationSocial mediaSevere acute respiratory syndrome coronavirus 2President of the United StatesDonald TrumpPseudoviridaeDNA replicationHEK 293 cellsLaboratory mouseRegeneron PharmaceuticalsMedical ethicsSpurMonoclonal antibody
